The Institute of Cancer Research, London, is one of the world’s most influential cancer research organisations. Today, find out about our PhD opportunities, read about how NICE could bring new medicines into the NHS and hear about our Liver Cancer Appeal.
Paul Workman of the ICR calls for major changes to restock pipeline with innovative cancer treatments.
The ICR and The Royal Marsden will become the first institutions in the UK to own and develop world-leading MR Linac technology.
We’re searching for the brightest minds in cancer research. Our new studentships are now open.
Professor Paul Workman blogs about 5 ways which if implemented could help NICE bring innovative cancer medicines into the NHS.
Our PhD students make a real contribution to defeating cancer while working full-time in the lab
Our Development Office is here to help you support our work, however you choose to do so
Dr Chris Bakal is doing fundamental research into cancer – vital to finding new ways of attacking it.
Teams of biologists, chemists and computational scientists design new drugs to selectively attack tumours
Dr Angela Kukula works with pharmaceutical companies to help develop new cancer drugs, using her expertise to negotiate collaborations between the ICR and industry
We run clinical trials with The Royal Marsden – taking our lab results right to the bedside
Applications for our PhD studentships are now open. Our PhD students conduct world-class research projects, while our MSc in Clinical Oncology teaches about the latest in clinical practice.
Our Interim Chief Executive, Professor Paul Workman, shares his experiences on his blog, The Drug Discoverer.
The ICR’s research aims to learn more about cancer genetics and tumour biology – and use that information in discovering new treatments.
Your support can help us fight an often overlooked form of cancer, one that claims an increasingly large number of lives every year.
We work in close partnership with industry to take results into the clinic as soon as possible, and make sure our research delivers for cancer patients.
Find out more about the aims and achievements of our eight scientific divisions.
The whole model of cancer drug discovery is broken and in need of help: Prof Paul Workman featured on the @MailOnline http://t.co/4sV7mZd4yf
Smoke signals – tracking cancer through the metabolic signatures it gives off
How to beat cancer at the evolution game
Five ways that NICE could help bring innovative cancer medicines into the NHS